Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × Watchful Waiting × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 10 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 5 Colonic Neoplasms 4 Carcinoma, Renal Cell 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Uterine Cervical Dysplasia 2 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Ureteral Neoplasms 1 Thyroid Nodule 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Smoldering Multiple Myeloma 1 Retinoblastoma 1 Precancerous Conditions 1 Pleuropulmonary blastoma 1

Interventions

Specimen Handling 7 Biopsy 6 Cyclophosphamide 5 ruxolitinib 4 Mycophenolic Acid 4 Busulfan 4 fludarabine phosphate 3 fludarabine 3 Whole-Body Irradiation 3 Tacrolimus 3 Melphalan 3 Injections 3 Decitabine 3 Cyclosporine 3 Azacitidine 3 venetoclax 2 decitabine and cedazuridine drug combination 2 Sirolimus 2 Methotrexate 2 Granulocyte Colony-Stimulating Factor 2 veliparib 1 tocilizumab 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 gilteritinib 1 fedratinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡